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Abstract
Bacillus anthracis lethal toxin (LT) is a key virulence factor of anthrax and contributes significantly to the in vivo pathology.
The enzymatically active component is a Zn
2+-dependent metalloprotease that cleaves most isoforms of mitogen-activated
protein kinase kinases (MKKs). Using ex vivo differentiated human lung epithelium we report that LT destroys lung epithelial
barrier function and wound healing responses by immobilizing the actin and microtubule network. Long-term exposure to
the toxin generated a unique cellular phenotype characterized by increased actin filament assembly, microtubule
stabilization, and changes in junction complexes and focal adhesions. LT-exposed cells displayed randomly oriented, highly
dynamic protrusions, polarization defects and impaired cell migration. Reconstitution of MAPK pathways revealed that this
LT-induced phenotype was primarily dependent on the coordinated loss of MKK1 and MKK2 signaling. Thus, MKKs control
fundamental aspects of cytoskeletal dynamics and cell motility. Even though LT disabled repair mechanisms, agents such as
keratinocyte growth factor or dexamethasone improved epithelial barrier integrity by reducing cell death. These results
suggest that co-administration of anti-cytotoxic drugs may be of benefit when treating inhalational anthrax.
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Introduction
Inhalational anthrax is an infectious disease caused by the
uptake of aerosolized spores of the gram-positive bacterium Bacillus
anthracis into the airways. Alveolar macrophages and lung-resident
dendritic cells ingest these spores and migrate to nearby lymph
nodes, where intracellular germination and release of vegetative
bacteria occurs. After a slow onset B. anthracis divides rapidly in the
circulatory system, resulting in fulminant disease characterized by
respiratory distress, haemorrhage, shock and sudden death of the
host [1,2]. The rapid and lethal development of B. anthracis sepsis is
triggered by massive release of a tripartite bacterial exotoxin [3,4].
Anthrax toxin consists of protective antigen (PA), lethal factor (LF)
and edema factor (EF). PA constitutes the receptor-binding and
carrier protein, which is responsible for host cell attachment,
complex formation with LF and EF, cellular entry of the toxin
complex and intracellular release of LF and EF to endocytic
organelles or the cytoplasm [5]. EF is a calcium- and calmodulin-
dependent adenylate cyclase that raises intracellular levels of
cAMP, a second messenger altering the activity of signaling
molecules including guanine nucleotide exchange factors (i.e.
Epac), protein kinases (i.e. PKA) and certain ion channels [6]. The
pathological consequences of the combined binary edema toxin
(ET; PA and EF) range from imbalance of fluid homeostasis and
edema formation in lungs to inhibition of chemotaxis and
phagocytosis, and suppression of angiogenesis in endothelial cells.
LF is a Zn
2+-dependent metalloprotease that specifically cleaves
almost all of the mitogen-activated protein kinase (MAPK) kinases
(MKKs) [7,8]. The cleavage occurs close to the N terminus of
MKKs and removes the so-called D-domain, a MAPK docking
motif, thereby decreasing MKK-MAPK binding affinity and
MKK-induced phosphorylation and activation of MAPK. MKKs
provide a crucial link from many cell surface receptors to Erk,
JNK and p38, and thus mediate the regulation of many
transcriptional networks by mitogenic and stress signals. Binary
lethal toxin (LT; PA and LF) has been connected to caspase-1-
dependent cell death of susceptible innate immune cells, to
endothelial cell apoptosis, and to cell cycle arrest in epithelial cells
[9]. LT alters the host immune response by abolishing cytokine
production and expression of co-stimulatory molecules. Recently,
LT was linked to decreased neutrophil chemotaxis due to reduced
actin filament assembly and to inhibition of actin-based motility of
the intracellular pathogen Listeria monocytogenes in HeLa cells
[10,11]. Not all of LT’s detrimental effects on host cells seem to
be a consequence of abolished MKK function. Specifically, LT-
induced cell death has not been conclusively linked to MKKs [3],
suggesting that other LF target proteins may exist.
Although interference with anti-bacterial responses of the host
innate and adaptive immune system is important for B. anthracis’
ability to replicate rapidly, non-immune cells seem to contribute to
the severity and fatality of B. anthracis infection when bacterimia-
induced toxin concentrations reach considerable levels. Injection
of mice with purified LT results in increased vascular leakage,
pleural edema and hypoxic tissue injury [12]. Similarly, patho-
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chimpanzees and inhalational anthrax victims are hemorrhages,
pleural effusion and edema [13]. This phenotype suggests that the
barrier function of the endothelium might be affected by LT. In
fact, LT caused significant endothelial barrier dysfunction in
primary human microvascular endothelial cells [14]. This effect
was not caused by apoptosis, although caspase-dependent
apoptosis in LT-treated HUVEC was reported elsewhere [15].
The observed increase in permeability, causing fluid leakage, could
not be mimicked by suppressing all three MAP kinase pathways
with chemical inhibitors and thus, the underlying mechanism of
endothelial junction disruption by LT remains unresolved.
The clinical manifestation of anthrax rarely includes broncho-
pneumonia in the earlier stages of the disease. In contrast, the final
sepsis and shock stage of infection is characterized by respiratory
distress and pulmonary edema. This may indicate that the airway
epithelium plays not only a role in dissemination of B. anthracis
infection [16], but that breakdown of the lung epithelial barrier is
also a crucial, late event in anthrax lethality. In this study, we
report that lethal toxin has a profound destructive effect on the
barrier function of differentiated human airway epithelium. This
LT-induced phenotype is the consequence of altering major
components of the mammalian cytoskeleton and microtubule
network, causing a state of permanent paralysis where turnover of
structural components is greatly reduced. Lung epithelial cell
functions, which require sustained dynamic regulation such as
directed migration and multicellular junction reorganization, were
abolished by LT. The structural paralysis of airway cells is MAPK
pathway-dependent and can be efficiently counteracted by
introducing non-cleavable MKK mutants. As this approach is
currently not a therapeutic option, several compounds recognized
for lung-protective function were assessed for their ability to
reduce toxin-induced barrier damage.
Results
Lethal toxin destroys the barrier function of human
mucociliary lung epithelium
To study the effect of B. anthracis toxins on the respiratory
epithelium, a three-dimensional (3D) model of polarized, muco-
ciliary lung epithelium was established. Primary human lung
epithelial cells were grown on extracellular matrix-coated filters in
air-liquid interface for 3–4 weeks. The differentiated phenotype
was characterized by a marked morphological change, giving rise
to a multicellular layer consisting of basal cells, non-ciliated cells,
ciliated cells and goblet cells (Figure S1A). The ex vivo differentiated
airway cells formed tight and adherens junction complexes,
produced mucus and expressed defensins and surfactant (Figure
S1B–D). Human lung epithelial cells expressed both anthrax
receptors, TEM8/ATR and CMG2 (Figure S1E) as previously
demonstrated in human lung tissue for TEM8 [17]. This model
system was used to determine if circulating B. anthracis exotoxins
alter lung epithelial cell functions. Addition of protective antigen
(PA) alone or edema toxin (ET; PA and EF) into the media in the
bottom chamber did not alter barrier function (Figure S2A), while
basolateral application of lethal toxin (LT; PA and LF) caused a
significant decrease in transepithelial electrical resistance and a
substantial increase in permeability of the layer to fluorescently
labeled albumin applied from the apical side (Figure 1A).
Transmission electron microscopy revealed that treatment of the
3D epithelium with LT caused an expansion of the epithelial layer
and the appearance of large paracellular spaces (Figure 1B).
Staining of the untreated and LT-treated epithelium with the tight
junction marker ZO1 showed disruption of the apical junction
network at multicellular connection sites (Figure 1C). When
exposed to LT, human lung epithelial cells cultured in typical 2D
conditions, did not exhibit any signs of apoptosis as judged with
caspase 3-mediated cleavage of poly (ADP-ribose) polymerase
(PARP) cleavage, by analysis of phosphatidylserine exposure, by
DNA laddering or by transferase mediated dUTP nick end
labeling (TUNEL) staining. However, up to 5% of cells detached
during the first 48 hours of treatment. This loss of attached cells
did not accelerate substantially after prolonged incubation in
growth factor-containing media, although LT-treated cells failed
to resume proliferation (Figure S2B). In polarized lung epithelium
a minor, but reproducible increase of cell death was observed after
48 hours of LT treatment (Figure 1D), which would be sufficient
for loss of barrier function if junction complex remodeling is
disturbed.
Increase and redistribution of junction proteins by lethal
toxin
Comparison of tight junctions (TJ) in untreated versus LT-
treated 3D model systems did not reveal clear differences in ZO1
distribution between two adjacent cells (Figure 1C). Analysis of
lung epithelial cells grown in 2D conditions undergoing LT
treatment clearly showed an increase of the TJ marker ZO1 along
the border of adjoining cells (Figure 2A). ZO1 was concentrated in
punctate structures lining cell-cell contacts. Similarly, the adherens
junction (AJ) protein E-cadherin was up-regulated in cells exposed
to LT (Figure 2B). Although the overall cell morphology of lung
epithelial cells was retained, E-cadherin-containing cell junctions
were less focused and more dispersed. Subcellular fractionation
did not only confirm the confocal analysis, but indicated a
redistribution and enrichment of both junction proteins in the
cytoskeletal fraction (Figure 2C).
Lethal toxin-induced reorganization of the cytoskeleton
and microtubule network
The apical junctional complex, composed of TJs and AJs, is
intimately connected with the actomyosin cytoskeleton via several
connections including a ZO1-cortactin linkage and an E-cadherin-
catenin-Rho GTPase axis. Confocal images of untreated and LT-
treated lung epithelial cells revealed a circular pattern of ordered
actin bundles in star-like formation as well as large, distinct
filamentous actin-containing protrusions (Figure 3A). As F-actin
content in general was enhanced (Figure 3A, 3F), analysis of the
actin depolymerization/polymerization cycle was performed.
Quantification of remaining F-actin filaments after 1 hour of
cytocholasin B treatment showed delayed actin depolymerization
in cells exposed to LT (Figure 3B). After washout F-actin filaments
repolymerized into the originally observed phenotypes in control
and LT-treated cells (data not shown). Incubation of LT-treated
cells with latrunculin A, which prevents actin polymerization by
forming complexes with actin monomers, produced a depolymer-
ization delay similar as illustrated for cytocholasin B (data not
shown). The microtubule network and the actin cytoskeleton are
interdependent, and thus profound actin reorganization is likely
accompanied by changes in the microtubular system. Untreated
primary lung epithelial cells displayed a radial meshwork of thin
and wavy a-tubulin-containing structures. Exposure to LT
produced a different pattern, where long microtubules extended
straight to the cell periphery and into the large protrusions,
resembling a ‘‘combed’’ phenotype (Figure 3C). Depolymerization
of microtubules with nocodazole was delayed in toxin-treated cells
as visualized by staining for stable microtubules using an antibody
recognizing acetylated tubulin (Figure 3D). We also noticed
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incubation with LT. Confocal analysis of vinculin-containing focal
adhesions (FA) revealed a more elongated FA phenotype
(Figure 3E), although the total number of focal contacts remained
unchanged. A substantial increase of proteins connected to focal
adhesions such as vinculin, paxillin and cortactin and their
redistribution to the cytoskeletal fraction was observed (Figure 3F).
MKK/MAPK inhibition mimics lethal toxin-mediated lung
cell motility defects
The dynamic reorganization of the actin cytoskeleton regulates
spatial organization of transmembrane proteins and thus plasma
membrane dynamics required for polarization and directed
migration. The altered physical state of LT-treated lung epithelial
cells suggested distinct mechanical properties of these cells after
intoxication. Time-lapse videomicroscopy of randomly migrating
lung epithelial cells showed leading edge formation and persistent
movement of polarized cells. After 24–48 hours of LT treatment
cells remained stationary lacking microtubule organizing center
(MTOC) polarization, but ruffled profoundly, exhibiting large,
highly mobile protrusions, as visualized by actin and tubulin
staining (Figure 4A, Movie S1, S2).
Figure 1. LT destroys barrier function in differentiated
mucociliary human lung epithelium. (A–D) Polarized NHBE were
treated with or without LT for 48 h. (A) The epithelial layer was
subjected to resistance measurements (left panel) or incubated with
FITC-albumin on the apical side for permeability measurements (right
panel). Data are represented as mean+/2SEM of 3–5 inserts/per
condition, n=3. (B) TEM images of crosscuts obtained from untreated
(-) and LT-treated lung epithelial layers. Crosscuts with ciliated cells on
the apical side are depicted. Scale bar represents 10 mm. (C) Confocal
images of the apical side of untreated and LT-treated lung epithelial
layers using a tight junction marker (ZO1, green). Z-series was analyzed
with Imaris5 (Bitplane Inc., MN). Disruptions of multicellular junctions
are indicated by white arrows. The scale bar represents 50 mm. (D) LDH
release of untreated and LT-treated NHBE 3D layers. Data are
represented as mean+/2SEM of 3 inserts, n=3.
doi:10.1371/journal.pone.0004755.g001
Figure 2. Junction proteins are elevated after LT treatment. (A,
B) NHBE cells were treated with or without LT for 48 h and stained with
ZO1 (A) or E-cadherin (B). Confocal images were taken consecutively.
Scale bar represents 50 mm. (C) Fractionation of LT-treated and
untreated (-) NHBE cells into cytosol (CYT), membrane (MEM) and
cytoskeletal (CSK) fractions. Immunoblotting was performed using anti-
E-cadherin and anti-ZO1. Rho GDI served as cytosol marker.
doi:10.1371/journal.pone.0004755.g002
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2D and 3D conditions, cleaving MKK1-7 (except MKK5) in 1–
2 hours as observed in other cell types. Even after 48 hours of
incubation with LT, MKK cleavage was sustained and MKK
proteins could not be detected (Figure S3B–C). As reported earlier
in macrophages [18], this loss of MKKs is not due to reduced
MKK transcription (Figure 3D). As MAPKs have been implicated
in cytoskeletal dynamics and their upstream signaling partners
MKKs represent the only identified LT targets, we reasoned that
the striking, LT-induced cell morphology changes could be
triggered by LT-mediated disabling of the Erk, JNK or p38
pathway. Inhibition of these signaling cascades can be mimicked
by incubation with chemical inhibitors of the kinase activity of
MKK1/2 (U0126; for downstream Erk1/2 inhibition), of JNK
(JNKII) and of p38 (SB203580). All three inhibitors altered the
morphological phenotype and cell motility of lung epithelial cells,
although JNK inhibition changed the cell shape in a distinct
manner, leading to overall cell contraction. The combined use of
all three inhibitors, a treatment mimicking LT action on MAPK
activity, resembled closely the LT-induced phenotype (Figure 4B,
Movie S3, S4, S5, S6, S7 and S8).
Formation and orientation of a single stable protrusion together
with the polarization of the MTOC is a prerequisite for directed
migration. The morphology observed in lung epithelial cells after
LT exposure suggested defects in cell functions, which rely on
directed migration such as chemotaxis or wound healing. Using
growth factors as chemotactic stimulus, complete inhibition of lung
epithelial cell migration through Boyden chambers was observed
when cells were treated with LT or the three inhibitor
combination (Figure 4C). Both, untreated and LT-treated cells,
were reseeded on fibronectin-coated filters for these experiments,
since adherence on collagen or fibronectin matrix was not altered
after exposure of cells to LT (Figure S3A). In all conditions
attachment to the top of the filter occurred similarly well.
Polarized primary lung epithelial cell layers exhibit a rapid
wound healing response where even a large wound closes in 18–
22 hours. Scratch assays were performed on untreated or LT-
treated epithelial layers, which were then compared to wounded
3D layers treated with MKK/MAPK inhibitors (Figure 4D, 4E).
Catalytically active LT inhibited wound closure, while an inactive
LT mutant (LT E687C) had no effect. Application of MKK1/2,
JNK or p38 inhibitors in combination resembled the LT-induced
block in wound healing, while each inhibitor by itself led only to
partial inhibition.
Role of Rho GTPases in LT-mediated motility defects
The changes in cytoskeletal and microtubule dynamics
including the pronounced membrane ruffling of LT-treated cells
suggested alterations in the activity of Rho GTPases. Cdc42, Rac1
and RhoA have been well established as mediators of dynamic
reorganization of the actin cytoskeleton, microtubule dynamics
and junction maintenance in epithelial cells [19,20]. The distinct
protrusion and stress fiber formation may indicate aberrant Rho
GTPase activation by LT. Thus, cell lysates from untreated and
LT-treated lung epithelial cells were probed for Rho GTPase
activity using pulldown assays. While Rac1 and RhoA activity did
not change, an increase in active GTP-bound Cdc42 was observed
(Figure S4A). Directed migration is dependent on tight spatio-
temporal control and cycling between on and off states, and could
be disrupted by locking Cdc42 into the activated state. Although
increased RhoA activity was not detected, we probed if inhibition
of downstream effectors of Rho, ROCK-1 and MLCK, could
suppress some of morphological features of LT-treated cells. The
ROCK-1 inhibitor Y27632 rescued partially the LT-mediated
increase of E-cadherin and the diffuse junction expansion, while
the MLCK inhibitor ML-7 was ineffective (Figure S4C and data
not shown). However, Y27632 did not prevent the LT-induced
permeability increase in polarized 3D lung epithelium (Figure
S4B). The phosphorylation status of cofilin, a ROCK-1/PAK
target required for motility [21,22], was also analyzed. Untreated
and LT-treated lung epithelial cells did not differ in their phospho-
cofilin content (data not shown).
Rescue of migration defects by non-cleavable MKKs
Emerging data implicate signaling by MAP kinases and MKK-
containing scaffolds in cellular processes required for migration
[23,24]. As the combination of chemical inhibitors for all three
MAPK pathways reproduced the LT-induced phenotype in lung
epithelial cells, mutants for all six, LT-targeted MKKs were
prepared. The LT cleavage sites for MKKs have been identified
[25] and single or multiple mutations were introduced into
wildtype MKKs to destroy these sites. Transiently transfected
MKK mutants were tested for expression, resistance to LT
cleavage and their ability to relay exogenous signals to specific
downstream MAPKs in LT-treated cells (Figure S5A). Non-
cleavable MKKs were cloned into GFP-coexpressing lentiviral
vectors to virally transduce primary lung epithelial cells. Live cell
imaging indicated that introduction of single MKK mutants did
not rescue the LT phenotype (data not shown). In order to
transduce cells stepwise with pairs of MKKs required for signaling
to Erk1/2, JNK, or p38 (MKK1,2; MKK4,7; MKK3,6) selection
and sorting of cells was necessary. Thus, immortalized human lung
epithelial cells (SALE) were used, which have been extensively
characterized in the laboratory and show many of the hallmarks of
primary lung epithelial cells. SALE cells transduced with GFP in
combination with non-cleavable MKKs (Figure S5B) were
subjected to a wound healing assay in 2D cell culture conditions
as only primary, low passage cells can differentiate to the typical
multicellular, polarized epithelial layers. In these conditions,
expression of all three MKK pairs permitted efficient wound
closure in LT-treated cells (Figure 5A). We tested if chemotaxis in
Boyden chambers would be restored by expression of non-
cleavable MKKs. Only introduction of the non-cleavable
MKK1,2 pair overcame the LT-induced block in directed
migration (Figure 5B). Non-cleavable MKK3,6 expression slightly
improved the LT-mediated inhibition of chemotaxis, but was
clearly less effective. Time-lapse videomicroscopy confirmed that
expression of the MKK1/MKK2 mutant pair, which cannot be
altered by LT and maintains its ability to signal to MKK1,2
targets including Erk1,2, restored reorientation of the MTOC,
leading edge formation and motility (Figure 5C, Movie S9, S10,
S11 and S12).
Figure 3. LT induces stress fiber formation and stabilized microtubules. (A, C) Immunofluorescence images of NHBE cells with or without LT
treatment (48 h). Cells were stained for actin (A, red) or a-tubulin (C, green). Scale bar represents 20 mm. (B, D) Cells with or without LT treatment
were incubated for 1 h with 1 mg/ml cytochalasin B (CytoB) (B) or 10 nM nacodazole (Nac) (D) and stained for actin (red, B) or acetylated tubulin (D,
green). Scale bar represents 50 mm. Remaining actin stress fibers (B) or stable microtubules (D) were quantified in 500 cells/per condition. (E) Confocal
images of NHBE cells treated with or without LT and stained with vinculin (green). Scale bar represents 50 mm. (F) Fractionation of LT-treated and
untreated (-) NHBE cells into cytosol (CYT), membrane (MEM) and cytoskeletal (CSK) fractions. Immunoblotting was performed using the indicated
antibodies. Rho GDI served as cytosol marker.
doi:10.1371/journal.pone.0004755.g003
Lethal Toxin and Motility
PLoS ONE | www.plosone.org 5 March 2009 | Volume 4 | Issue 3 | e4755Lethal Toxin and Motility
PLoS ONE | www.plosone.org 6 March 2009 | Volume 4 | Issue 3 | e4755Partial rescue of barrier function by keratinocyte growth
factor and dexamethasone
Extensive denudation of the lung epithelium will not occur
during anthrax infection. As shown, lung epithelial cells ceased to
proliferate, but did not succumb to extensive cell death (Figure
S2B). The LT-induced decrease in barrier function is likely caused
by expulsion of single cells from the layer, which cannot be
repaired due to the mechanical stiffness and motility defects caused
by MKK cleavage. In accord, inhibition of MKK/MAPK
signaling by chemical compounds was not pro-apoptotic, but
reduced barrier integrity (Figure 6A). As LT inhibitors are not yet
available and introduction of non-cleavable MKK1,2 is not a
viable treatment option, a screening for barrier-protective drugs
was initiated. Compounds, which have been used successfully for
treatment of lung epithelial injury were tested for their ability to
protect barrier integrity during LT exposure [26–28]. Two
compounds, keratinocyte growth factor (KGF) and dexametha-
sone, rescued barrier function significantly (Figure 6B–C). Both
compounds did not alter LT-induced changes of the cytoskeletal
or microtubule network in 2D conditions (data not shown). We
reasoned that if less cells would be expelled from the epithelial
layer, the disruption of multicellular junctions would be reduced,
even if LT-paralyzed motility had not been restored. Supporting
this hypothesis, KGF and to a lesser degree dexamethasone
reduced LT-mediated epithelial cytotoxicity considerably
(Figure 6D), and thus seem to protect barrier integrity of the lung
epithelium by extending cell survival.
Discussion
In this study, the effect of long term exposure of lung epithelium
to B. anthracis lethal toxin, which enters every mammalian cell type
and acts by blocking intracellular MKK-MAPK signaling cascades
permanently, was determined. MKK-MAPK pathways mediate
crucial signals from the extracellular milieu to gene transcription,
thus affecting cell proliferation, apoptosis, differentiation and
inflammatory mediator release. Accumulating evidence suggests
that MAPKs might also control cell migration, although the
precise mechanism remains obscure [23,24]. After 24 hours of LT
exposure, complete MKK1-7 (except MKK5) deficiency was
observed in lung epithelial cells, which was maintained over the
observation period of up to 4 days. LT-mediated cytoskeletal
alterations, present after the first 24 hours, were sustained even
when a depolymerization / repolymerization cycle was induced by
addition and subsequnent removal of depolymerizing agents. The
presence of multiple overlapping cytoskeletal targets, which
control actin and microtubule dynamics indicate that coordinated
input from all three major MAPK pathways might be important
for maintenance of cell shape and motility. The distinct
morphological and functionally paralyzed phenotype caused by
exposure of primary human lung epithelial cells to LT supports
this notion. Some networks involved in motility may have
redundancy, as the successful 2-dimensional wound closure by
three different pairs of non-cleavable MKKs suggests. On the
other hand, introduction of single non-cleavable MKKs into lung
epithelial cells was not sufficient for reversal of paralyzed actin and
microtubule networks. Thus, one may speculate that MKK1 and
MKK2 may trigger not only Erk1 and Erk2 signaling pathways.
MKKs may participate in interactions with molecules essential for
connecting membrane dynamics with actin assembly such as
cortactin or MP1 [24,29]. The morphological phenotype of LT-
treated lung epithelial cells showed mechanical stiffness of the cell
body with increased F-actin content and redistributed focal
adhesion proteins in concert with highly dynamic, randomly
oriented protrusions. Upregulation of b-actin by LT was also
reported by comparative proteomics studies on mouse macro-
phages [30]. In contrast, fMLF-stimulated F-actin filament
assembly was reduced in LT-treated neutrophils [10]. The same
group reported decreased actin assembly of Listeria rocket tails in
HeLa cells exposed to LT [11], which was linked to defective actin
monomer transport by Hsp27, a phosphorylation target of p38
MAPK. In our study, F-actin content was increased and
introduction of non-cleavable MKKs upstream of p38 MAPK
rescued 2-dimensional lung epithelial wound healing only if
signaling by both, MKK3 and MKK6, was restored. This rescue
was not specific for the MKK3/MKK6 pair and did not improve
chemotaxis. The cytoskeletal networks of neutrophils that are
required for priming responses, polarization, and chemotaxis are
quite distinct, and likely controlled by different signaling pathways
than those important for cytoskeletal responses and junction
formation in other cell types. Endothelial cells, which also form a
tight barrier, seem to undergo cell elongation after LT treatment
and succumb more or less to apoptosis [14,31]. MKK/MAPK
signaling seems not to be required for all cytoskeletal remodeling
processes. For example, the actin reorganization required for
phagocytosis was fully maintained in bone marrow-derived murine
macrophages subjected to prolonged LT treatment (strain C57Bl/
6; unpublished observations).
The plasma membrane of LT-exposed lung epithelial cells
showed multiple, highly active protrusions without formation of a
leading edge or MTOC polarization. Development and extension
of protrusions is under control of Rho GTPases. The observed
enhancement of Cdc42 activity in LT-treated cells might be a
redistribution effect of signaling molecules, including unidentified
Cdc42 GAPs, once MKKs have been cleaved and degraded. As
GTPase cycling between the on and off state is essential for
protrusion formation, this increase of Cdc42 activity may cause
deregulation of the Cdc42-GSK3-APC pathway [32]. Blocking
GSK-3 leads to randomly oriented protrusions and inhibition of
MTOC re-orientation [33]. Additionally, GSK-3-mediated phos-
Figure 4. LT mediates polarization and motility defects in airway cells. (A) A representative frame of bright field live cell movies of untreated
and LT-treated NHBE (48 h) after global growth factor stimulation (see Methods). Scale bar represents 20 mm. The complete movies (Movie S1
untreated and Movie S2 LT-treated) are in Supplemental data. (B) One representative frame of bright field live cell movies of untreated (-), LT-treated
(48 h) or MKK/MAPK inhibitor-treated (48 h) NHBE cells after global growth factor stimulation (see Methods). Scale bar represents 20 mm. The
corresponding movies (S3–8) can be found in the Supplemental part. (C) Chemotaxis of untreated (-), LT-treated (48 h) or MKK/MAPK inhibitor-
treated (48 h) NHBE in Boyden chambers. 3INH is a combination of three inhibitors (U0126, SB203580, JNKII). Cells were stained with rhodamine
phalloidin (red) and DAPI (blue). Upper panels depict cells on the top of the membrane after 1 h of plating before growth factors were added to the
bottom chamber. The lower panels show cells on the bottom of the filter 21 h after addition of growth factors. Scale bar represents 50 mm. (D)
Immunofluorescence imaging of wound healing assay using polarized NHBE (actin, red). Untreated (-) 0 h image displays the original scratch,
whereas all other images were taken 24 h later. Cells were left untreated or treated with LT, catalytically inactive LT (E687C), 3INH combination, or
inhibitors for MKK1/2 (U0126), p38 (SB203580) or JNK (JNKII) for 48 h before the scratch was performed. Scale bar represents 100 mm. (E)
Quantification of experiment shown in (D). Data (mean+/2SEM) are represented as width of the wound of 4–8 different areas with 2 inserts/
condition. The overall analysis of variance between all groups was highly significant: F6,604=675.4, p,0.0001.
doi:10.1371/journal.pone.0004755.g004
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[34]. Deregulation of the Cdc42-GSK-3 pathway by LT intoxica-
tionissupportedbyobservationsthat GSK-3proteinlevelsdecrease
considerably in LT-treated macrophages [35]. Introduction of non-
cleavable MKK1 and MKK2 into lung epithelial cells restored
normal protrusion formation and migration towards a chemotactic
gradient, suggesting that the MKK1/2-Erk1/2 signaling axis serves
as important upstream regulator of protrusion formation.
Figure 5. LT-mediated migration defects are MKK-dependent. (A) Live cell wound healing assay was performed in untreated or LT-treated
airway cells (SALE) expressing non-cleavable MKK1/2, MKK3/6 or MKK4/7 mutants or EGFP alone as control. Cells were imaged at time zero and 24 h
after the scratch. Scale bar represents 50 mm. Quantification of experiment is shown in lower panel. Data (mean+/2SEM) in each experiment were
obtained from 10 different wound areas, n=3. The overall analysis of variance between all groups was highly significant: F7,72=49.6, p,0.0001. (B)
Chemotaxis of untreated and LT-treated airway cells expressing non-cleavable MKK1/2, MKK3/6 or MKK4/7 using Boyden chambers (migration for
21 h). Cells on the bottom of the filter were stained with DAPI (blue). Upper panel depicts untreated cells, lower panel LT-treated cells. Scale bar
represents 50 mm. (C) A representative frame of bright field live cell movies of untreated and LT-treated airway cells expressing EGFP or non-cleavable
MKK1/2-/EGFP after global growth factor stimulation. Scale bar represents 20 mm. Complete movies (S9–12) can be found in Supplemental data.
doi:10.1371/journal.pone.0004755.g005
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epithelium. Assuming that our polarized lung epithelial cell model
reflects the airway epithelium in vivo, our data suggest that this
barrier will be destroyed by uptake of high LT quantities over a
prolonged time during the final stage of anthrax infection. In
addition, the observed cytoskeletal changes will lead to an inability
to repair the epithelium. The initial damage seems not to be
massive cell death and tight junction destruction, but rather
expulsion of senescent single cells as observed as prerequisite for
Listeria invasion [36]. In healthy conditions, rapid formation of
new multicellular junctions will repair the damage and restore the
barrier. Exposure to LT increases cytotoxicity and thus the
expulsion rate, and hinders repair by MKK cleavage-induced
inhibition of actin and microtubule dynamics in the neighboring
lung epithelial cells. Treatment with KGF or the synthetic
glucocorticoid dexamethasone alleviated LT-mediated barrier
damage significantly, thus providing a potential therapeutic option
for anthrax victims. Both of these agents have previously been
implicated in lung epithelial repair mechanisms [37]. Although we
could not confirm direct effects of these drugs on cytoskeletal
dynamics, our data point to a decrease in LT-induced cytotoxicity,
specifically after KGF pretreatment, and thus to enhanced survival
of LT-exposed polarized lung epithelial layers. The respiratory
distress of critically ill anthrax patients might be caused by LT-
mediated breakdown of the respiratory barrier and influx of fluid
into the lungs. Preventative therapy with KGF may strengthen the
airway barrier and improve lung function.
Materials and Methods
Antibodies, plasmids, PCR and inhibitors
Antibodies directed against ZO-1, streptavidin-HRP, GFP
(A6455), mouse/rabbit alexa fluor 488, 568, 594 were from
Invitrogen (Carlsbad, CA); MKK1 (C-18), MKK2 (C-16), MKK3
(C-19), MKK4 (C-20), MKK4 (K-18), RhoGDI (A-20), RhoA,
Cdc42 were from Santa Cruz (Santa Cruz, CA); gelsolin (GS-
2C4), acetylated tubulin (T6793), b-actin (A2066), a-tubulin
(DM1A), vinculin (hVIN-1) were from Sigma Aldrich (St. Louis,
MO); p38 MAPK, phospho-p38 MAPK (Thr180/Thr182), p44/
42 MAP kinase, phospho-p44/42, pSAPK/JNK (Thr183/
Thr185,) SAPK/JNK (56G8), and FAK were from Cell Signaling
(Danvers, MA); paxillin, E-cadherin, MKK2, and Rac1 from BD
Biosciences (Franklin Lakes, NJ); MKK6 from Biolegend (San
Diego, CA); MKK7 (ab18565) was from Abcam (Cambridge,
MA); cortactin (p80/85 clone 4F11) from Millipore; MKK1 (N-
term) from Chemicon (Temecula, CA). Mammalian expression
vectors containing MKK3 (I27E) and MKK6 (I15A) were from
Michael David (UCSD), MKK1wt and MKK2wt from Kun-
Liang Guan (U. of Mich.), and pcDNA3 MKK7wt was provided
by Jiahuai Han (TSRI). pBluescriptR MKK4wt was from Open
Biosystems (Huntsville, AL) (clone ID 5272439). Point mutations
for MKK1 (P8A), MKK2 (P10A), MKK4 (K45Q, K46E, R58Q,
F59D) and MKK7 (Q44K, G76A) were introduced by Quick-
ChangeH Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA)
and verified by sequencing. Mutant MKKs were cloned into the
lentiviral vector CGW-IRES-EGFP. The CGW vector and the
lentiviral plasmids for GAG/pol, VSV-G and pRSV-rev were
provided by Bruce Torbett (TSRI). Conditions and primers for
RT-PCR are described in Methods S1. Inhibitors for p38
(SB203580, 10 mM; SB202190, 10 mM), MKK1/2 (U0126,
5 mM), JNK (JNKII, 5 mM), ROCK-1 (Y27632, 10 mM) and
dexamethasone (10 mM) were purchased from EMD Biosciences
(San Diego, CA). Cytocholasin B (1 mg/ml), nocodazole (10 nM),
MTT (0.5 mg/ml), DAPI (1 mg/ml), PMA (100 ng/ml), fibronec-
tin (10 mg/ml), human placenta collagen type VI (10 mg/ml) and
rhodamine phalloidin were from Sigma Aldrich (St. Louis, MO).
EF was from List Biological Laboratories, Inc. (Campbell, CA). LF
(E687C) was a gift from Nick Duesbery (Van Andel Research
Institute, MI) and keratinocyte growth factor (250 ng/ml) was
purchased from Cell Sciences (Canton, MA). TNFa was from
Thermo Fisher Scientific Inc. (25 mg/ml, Rockford, IL). Expres-
sion and purification of PA and LF is described in Methods S2.
Cell culture
Normal human bronchial epithelial cells (NHBE) were
purchased from Lonza (Walkersville, MD) and used at passage
3–5. SALE cell were a gift of W. C. Hahn [38]. Cells were grown
in serum-free medium (SABM, Lonza) supplemented with SAGM
SingleQuots (Lonza). A polarized lung epithelial model (3D) was
established by seeding NHBE cells onto inserts with semi-
permeable support membranes (Transwell culture insert, 0.4 mm
pore, Corning, Lowell, MA) coated with human placenta collagen
type VI (15 mg/cm
2, Sigma Aldrich, St. Louis, MO). For
differentiation, airway epithelial cells were grown in 50% SABM,
50% DMEM high glucose supplemented with SingleQuots and
50 nM retinoic acid. Cells were grown in air-liquid interface for 3–
4 weeks. HeLa and HEK293T cells were cultured in DMEM high
Figure 6. Keratinocyte growth factor and Dexamethasone
partially rescue lung barrier function by reducing cell death.
(A) Permeability measurements were performed in the ex vivo
differentiated NHBE treated with or without LT (1 mg/ml LF/PA), a
three inhibitor combination (3INH / U0126, SB203580, JNKII) or
catalytically inactive LT (1 mg/ml LF E687C/PA) for 48 h. (B–D) Polarized
NHBE layers were treated for 1 h with KGF (250 ng/ml) or dexameth-
asone (10 mM) before LT (1 mg/ml) was added for 48 h. Layers were
analyzed for resistance (B), permeability (C) and LDH release (D). Data
(A–D) are represented as mean+/2SEM of 3 inserts/condition. The
overall analysis of variance in A–D between all groups was highly
significant: (A) F3,10=145.6, (B) F5,19=22.6, (C) F5,12=36.4, (D)
F5,12=63.3, p,0.0001.
doi:10.1371/journal.pone.0004755.g006
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starved for 3 h and treated with 1 mg/ml of PA, LF and/or EF for
24–48 h in media without supplements.
Lentivirus production and transduction
Non-cleavable MKK mutants were cloned into a bicistronic
CGW-IRES-EGFP vector [39]. Transfection of HEK293T cells was
with calcium chloride (10 mgt r a n s f e rv e c t o rp l a s m i d ,G A G / p o l
plasmid, VSV-G plasmid, pRSV-rev plasmid) in DMEM high
glucose. Virus suspension was filtered and concentrated by ultracen-
trifugation at 19400 rpm for 2.5 hours. SALE cells were transduced
with non-cleavable MKK mutants, sorted for medium EGFP
expressing cells by flow cytometry and consecutively transduced with
a second non-cleavable MKK mutant (FACS Vantage DiVa, BD
Biosciences, San Jose, CA). MKK and GFP expression levels of stable
SALE cell lines were verified by immunoblotting.
Immunofluorescence microscopy
NHBE cells were seeded on a glass coverslips coated with
human placenta collagen type VI (10 mg/ml). At 50–80%
confluency cells were fixed with 4% paraformaldehyde (actin,
vinculin), ice cold methanol (acetylated tubulin) or methanol/
acetone (ZO1, E-cadherin). After rehydration in PBS, permeabi-
lization with 0.5% Triton X-100 and blocking with 5% BSA in
PBS, coverslips were incubated for 1 h with primary antibody in
2% BSA/PBS. The secondary antibodies were anti-rabbit or anti-
mouse IgG conjugated with alexa-fluor-488 or -568 (Invitrogen,
Carlsbad, CA). All images were taking by confocal microscopy
(206or 636, MRC 1024, BioRad, Hercules, CA) with the same
laser power, gain and offset per antibody condition.
Migration assay in Boyden chambers
After LT treatment (1 mg/ml PA and LF) cells were reseeded in
SABM media without supplements on polycarbonate membrane
filters coated with fibronectin (pore size 8 mm). Migration occurred
towards SABM with SingleQuot supplements in the bottom
compartment for 21 h. Cells on top of the filter were removed,
while cells on the bottom of the filter were fixed with PFA and
stained with rhodamine phalloidin and DAPI. Images were taken
with an Axioskop microscope (Zeiss, Goettingen, Germany) by
using the AxioVision AC 4.2. software. Pictures were analyzed
with ImageJ (NIH, Bethesda, MD).
Wound healing assay
NHBE differentiated for 3 weeks and treated for 48 h with or
without LT and/or inhibitors were wounded using a pipette tip.The
cells were either fixed immediately as control or incubated for 24 h
and then fixed. After staining with rhodamine phalloidin confocal
images with a 106objective lens were taken (MRC 1024, BioRad,
Hercules,CA).ImageJ(NIH,Bethesda,MD)wasusedtoanalyzethe
width of the scratch. Two different inserts per condition and 6–8
images with 10 measurements per image were used. For wounding
assays in normal cell culture conditions SALE cells expressing non-
cleavable MKK mutants were plated on human collagen-coated,
etched grid coverslips (Bellco, Vineland, NJ) and grown to 100%
confluency. Cells were left untreated or treated for 24 h with LT
before wounding. Images of wounded cells were taken immediately
and 24 h later after incubation in SABM media with supplements
(Olympus IX70 microscope; Olympus, Center Valley, PA).
Live cell imaging
A Nikon Eclipse TE2000-U (Melville, NY) was used to generate
movies of untreated or treated NHBE or SALE cells. Cells were
plated on collagen-covered cover slips, grown for two days, starved
in SABM media for 3 hours and treated with 1 mg/ml PA and
1 mg/ml LF for 48 h (NHBE) or 24 h (SALE) prior to imaging. The
cells were washed with HBSS before SABM media containing
SingleQuot supplements (growth factors) was added just before live
cell imaging started. Bright field images were taken every 30–60 sec
for 40–120 min with a 206objective lens. Metamorph (Molecular
Devices Corp., Downingtown, PA) or ImageJ (NIH, Bethesda, MD)
were used to analyze the pictures and generate movies.
Transmission electron microscopy (TEM)
TEM of untreated and LT-treated differentiated NHBE was
performed as described [40].
Western blot analysis
Proteins were extracted in RIPA buffer (150 mM NaCl, 50 mM
Tris-HCl, pH 7.4, 0.5% sodium cholate, 1% NP-40, 0.1% SDS,
protease and phosphatase inhibitor cocktail (Roche, Indianapolis,
IN). SDS-PAGE was performed and the proteins were transferred
onto nitrocellulose membranes. Membranes were blocked with
5% BSA, incubated with specific and HRP-coupled secondary
antibodies. Bands were visualized using ECL (Thermo Scientific,
Rochford, IL).
Cell fractionation
NHBE cells were lyzed in fractionation buffer (25 mM Tris,
pH 7.5, containing 2 mM EDTA, pH 8, 10 mM b-mercaptoeth-
anol, 10% glycerol, 10 mg/ml leupeptin, 10 mg/ml aprotinin,
1 mM phenylmethylsulfonyl fluoride). The post-nuclear superna-
tant (10006g for 10 minutes) of sonicated cells was spun at
100,0006g for 30 minutes in an Optima TLX ultracentrifuge
(Beckman Instruments Inc., Palo Alto, CA). The supernatant
(cytosol) was frozen und the pellet was washed with fractionation
buffer. After incubation of the pellet on ice for 45 minutes in
fractionation buffer containing 1% (v/v) Triton X-100, triton-
soluble membranes were separated from the triton-insoluble
cytoskeletal fraction by centrifugation at 100,0006g for 30 min-
utes. The cytoskeletal pellet was washed and sonicated in an equal
amount of fractionation buffer.
GTPase activity assay
PBD pulldown assay for detection of Rac and/or Cdc42
activity, and the rhotekin Rho binding domain-based assay for
RhoA activity were performed like previously described [41,42].
Cell viability assays
MTT assay for cells grown in 2D: MTT (500 mg/ml) was added
to cells for 30 min or 1 h. After PBS wash the water-insoluble
purple formazan was dissolved in DMSO (Sigma Aldrich, St.
Louis, MO). Absorbance at 560 nm was determined for each well
using a microplate reader (Bio-Rad, Hercules, CA). LDH release
for cells grown in 3D: LDH was determined using the CytoTox-
ONE
TM Kit from Promega (Madison, WI). The fluorescence was
measured with an excitation wavelength of 560 nm and an
emission wavelength of 590 nm in a Synergy HT fluorimeter (Bio-
Tek Instrument Inc., Winooski, VT). Cytotoxicity (%) was
calculated as follows: Cytotoxicity (%)=1006(amount of LDH
in basal medium minus background) / (amount of LDH of lysed
apical cells minus background).
Adhesion assay
NHBE were grown for 2 days, starved for 3 h in SABM media,
and treated with 1 mg/ml PA and LF for 48 h. 24well plates were
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were seeded in triplicates. After 24 h cells were washed carefully
and adherent cells were stained with 500 mg/ml MTT.
Resistance measurements
Transepithelial electric resistance (TER) was measured by using
a voltohmmeter (EVOM) with STX2 electrode (World Precision
Instruments, Sarasota, FL).
Permeability measurements
FITC-coupled albumin (0.5 mg/ml in HBSS, A7016, Sigma
Aldrich, St. Louis, MO) was applied to the apical side of
differentiated NHBE. Leakage of the dye through the epithelial
layer was measured in samples removed from the bottom chamber
using an excitation wavelength of 485620 nm and an emission
wavelength of 530625 nm. The standard curve equation of x=y/
15.195 calculates the permeability of the cell layer in mg. The time
period of incubation and the insert surface was taken into account
for final calculation (mg/h/cm
2).
Statistical analysis
Data are represented as mean6SEM. Figure 1 was performed
with unpaired two-tailed t-tests. Significance levels were *,
P,0.05; **, P,0.01; ***, P,0.001. Overall comparison among
groups within Figure 4, 5, 6, S2, S4 was analyzed with one way
analysis of variance. If the overall F statistics from the one-way
ANOVAs were significant at the alpha=0.05 level, paired group
comparisons were performed with a Bonferroni correction for




Found at: doi:10.1371/journal.pone.0004755.s001 (0.03 MB
DOC)
Methods S2
Found at: doi:10.1371/journal.pone.0004755.s002 (0.04 MB
DOC)
Figure S1 Characterization of the polarized airway system and
expression of anthrax receptors in NHBE cells. (A) TEM image of
cross section obtained from untreated lung epithelial layers ALI-
cultured for 5 weeks. A crosscut with apical cilia, different cell
types including goblet cells, tight junction formation and cell
interdigitations is depicted. Scale bar represents 5 mm. (B)
Expression of differentiation markers caveolin 1, human defensins
1 (hBD-1) and 2 (hBD-2) in cell culture-plated cells (2D) versus
polarized airway system (3D) (RT-PCR). Actin served as loading
control. (C) Expression of surfactant A and B (SP-A, SP-B) in
differentiated lung epithelial layers (RT-PCR of 3D, see B). PCR
bands were not detected in 2D conditions (not shown). (D)
Increased MUC5AC expression in polarized lung epithelium (RT-
PCR). Actin was used as loading control. (E) Expression of anthrax
receptors ATR/TEM8 and CMG2 in NHBE 2D (RT-PCR).
Actin served as loading control.
Found at: doi:10.1371/journal.pone.0004755.s003 (1.34 MB TIF)
Figure S2 LT exposure leads to permeability increase and
proliferation inhibition in NHBE. (A) The epithelial layer was
incubated with FITC-albumin on the apical side for permeability
measurements after no, LT, ET and LT+ET treatment (48 h).
One representative experiment in triplicate is shown (data are
represented as mean+/2SEM). The overall analysis of variance
between all groups was highly significant: F3,8=397.4, p,0.0001.
(B) Untreated or LT-treated NHBE (48 h) were washed and
incubated with LT-free media containing growth factors for
additional 48 h (48+48) or 96 h (48+96). Metabolically active cells
were measured using the MTT assay. Data are represented as
mean+/2SEM of 3 independent experiments.
Found at: doi:10.1371/journal.pone.0004755.s004 (0.10 MB TIF)
Figure S3 Adhesion parameters and MKK expression profiles
after LT-induced MKK cleavage in NHBE cells. (A) LT-treated
(48 h) and untreated NHBE cells were reseeded on fibronectin- or
collagen-coated dishes. Number of cells attached after 21 h was
quantified using the MTT assay. Data are represented as mean+/
2SEM of 3 different experiments. (B) Immunoblot depicting MKK
cleavage after LT treatment (48 h) of NHBE cells grown in cell
culture conditions (2D). Actin served as loading control. (C)
Immunoblot depicting MKK cleavage in polarized NHBE cultures
(3D). Actin served as loading control. (D) Expression of MKK2 and
MKK3 in NHBE treatedwithPA or LT (RT-PCR).Actin served as
loading control. First lane represents no template control.
Found at: doi:10.1371/journal.pone.0004755.s005 (0.37 MB TIF)
Figure S4 Rho GTPase activity and effect of ROCK-1
inhibition on junctions. (A) Pulldown assays for Cdc42-GTP,
Rac1-GTP and RhoA-GTP with or without LT treatment for
48 h. Active, bound Rho GTPases were detected by immunoblot.
Total cell lysate (TCL) was used as loading control (5% of total).
(B) Permeability of polarized NHBE layers after no treatment, LT,
Y27632 and Y27632+LT treatment for 48 h. One representative
experiment in triplicate is shown (data are represented as mean+/
2SEM). The overall analysis of variance between all groups was
highly significant: F3,8=416.6, p,0.0001. (C) NHBE cells were
treated with or without LT, Y27632 and Y27632+LT and stained
for E-cadherin (green). Confocal images were taken consecutively.
Scale bar represents 50 mm.
Found at: doi:10.1371/journal.pone.0004755.s006 (3.00 MB TIF)
Figure S5 Validation of non-cleavable MKKs. (A) Non-
cleavable MKK mutants or empty vector plasmid were transiently
transfected into HeLa cells and expressed for 24 h followed by
24 h of LT treatment. Cells were then stimulated for 15 min with
PMA (100 ng/ml) or TNFa (25 mg/ml) to activate MKK/MAPK
pathways. Endogenous MKK expression; exogenous, non-cleav-
able MKK expression; LT-mediated MKK cleavage; phosphor-
ylation of MAP kinases Erk, p38 or JNK; and total Erk, p38 and
JNK expression are visualized by immunoblot as indicated. (B)
Lentiviral expression of non-cleavable MKK pairs (MKK1/2,
MKK3/6, MKK4/7) together with EGFP and of EGFP alone in
SALE cells (see Methods). Lysates of the four SALE cell lines were
probed by immunoblot with MKK specific and GFP antibodies.
Found at: doi:10.1371/journal.pone.0004755.s007 (1.45 MB TIF)
Movie S1 Random migration of untreated NHBE cells. Time-
lapse microscopy of untreated NHBE cells after global growth
factor stimulation. The movie shows bright field images taken
every minute over a time period of 2 h. The scale bar represents
20 mm.
Found at: doi:10.1371/journal.pone.0004755.s008 (2.49 MB AVI)
Movie S2 Inhibition of polarization and exaggerated protrusions
in LT-treated NHBE cells. Time-lapse microscopy of LT-treated
NHBE cells (48 h) after global growth factor stimulation. The
movie shows bright field images taken every minute over a time
period of 2 h. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s009 (2.64 MB AVI)
Movie S3 Motility of untreated NHBE cells. Time-lapse
microscopy of untreated NHBE cells after global growth factor
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30 seconds over a time period of 40 minutes. The scale bar
represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s010 (9.58 MB AVI)
Movie S4 Inhibition of motility in NHBE cells treated with LT.
Time-lapse microscopy of LT-treated (48 h) NHBE cells after
global growth factor stimulation. The movie shows bright field
images taken every 30 seconds over a time period of 40 minutes.
The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s011 (7.10 MB AVI)
Movie S5 Inhibition of motility in NHBE cells treated with a
triple MKK/MAPK inhibitor combination. Time-lapse micros-
copy of NHBE cells incubated with inhibitors U0126, SB203580
and JNKII (48 h) after global growth factor stimulation. The
movie shows bright field images taken every 30 seconds over a
time period of 40 minutes. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s012 (10.12 MB
AVI)
Movie S6 Inhibition of motility in NHBE cells treated with
MKK1/2 inhibitor. Time-lapse microscopy of NHBE cells
incubated with inhibitor U0126 (48 h) after global growth factor
stimulation. The movie shows bright field images taken every
30 seconds over a time period of 40 minutes. The scale bar
represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s013 (7.09 MB AVI)
Movie S7 Inhibition of motility in NHBE cells treated with p38
inhibitor. Time-lapse microscopy of NHBE cells incubated with
inhibitor SB203580 (48 h) after global growth factor stimulation.
The movie shows bright field images taken every 30 seconds over
a time period of 40 minutes. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s014 (4.69 MB AVI)
Movie S8 Inhibition of motility in NHBE cells treated with JNK
inhibitor. Time-lapse microscopy of NHBE cells incubated with
inhibitor JNKII (48 h) after global growth factor stimulation. The
movie shows bright field images taken every 30 seconds over a
time period of 40 minutes. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s015 (3.56 MB AVI)
Movie S9 Motility of SALE cells expressing EGFP. Time-lapse
microscopy of untreated SALE cells expressing EGFP after global
growth factor stimulation. The movie shows bright field images
taken every 30 seconds over a time period of 40 minutes. The
scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s016 (6.82 MB AVI)
Movie S10 Time-lapse microscopy of LT-treated (24 h) SALE
cells expressing EGFP after global growth factor stimulation. The
movie shows bright field images taken every 30 seconds over a
time period of 40 minutes. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s017 (5.57 MB AVI)
Movie S11 Motility of SALE cells expressing non-cleavable
MKK1/2 mutants. Time-lapse microscopy of untreated SALE
cells expressing non-cleavable MKK1/2 mutants after global
growth factor stimulation. The movie shows bright field images
taken every 30 seconds over a time period of 40 minutes. The
scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s018 (4.37 MB AVI)
Movie S12 Rescue of motility by non-cleavable MKK1/2
mutants in SALE cells treated with LT. Time-lapse microscopy
of LT-treated (24 h) SALE cells expressing non-cleavable MKK1/
2 mutants after global growth factor stimulation. The movie shows
bright field images taken every 30 seconds over a time period of
40 minutes. The scale bar represents 20 mm.
Found at: doi:10.1371/journal.pone.0004755.s019 (9.71 MB AVI)
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